Task: Answer the multiple choice question.
Query: Which drug exhibits a 2.486% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) COCc1cc(C)nc(SCC(=O)N2CCC(C)CC2)c1C#N
b) CCOC(=O)c1cc2cc(-c3c(C(=O)OCC)oc4cc(O)cc(O)c4c3=O)ccc2o1
c) CCCC(=O)Nc1ccc(NC(=O)C2CC2)cn1
Answer: c. CCCC(=O)Nc1ccc(NC(=O)C2CC2)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(=O)Nc1ccc(NC(=O)C2CC2)cn1
CCCC(=O)Nc1ccc(NC(=O)C2CC2)cn1
N-[6-(butanoylamino)pyridin-3-yl]cyclopropanecarboxamide